The Australian and New Zealand Cardiac Pacemaker and Implantable Cardioverter-Defibrillator Survey: Calendar Year 2013

Background A pacemaker (PM) and implantable cardioverter-defibrillator (ICD) survey was undertaken in Australia and New Zealand for calendar year 2013. Results and Conclusions For 2013, PMs sold as new implants in Australia was 15,203 (12,523 in 2009) and implanted in New Zealand were 1,641 (1,277 i...

Full description

Saved in:
Bibliographic Details
Published in:Heart, lung & circulation lung & circulation, 2015-03, Vol.24 (3), p.291-297
Main Authors: Mond, Harry G., OAM, MD, PhD, FRACP, FCSANZ, Crozier, Ian, MD, FRACP, FCSANZ
Format: Article
Language:English
Subjects:
ANZ Survey
Australia
Bipolar
Cardiac pacemakers
Cardiovascular
Cardioverter-Defibrillators
Defibrillators, Implantable
Female
Humans
Lead fixation
Male
New Zealand
Pacemaker leads
Pacemaker, Artificial
Retrospective Studies
Surveys and Questionnaires
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background A pacemaker (PM) and implantable cardioverter-defibrillator (ICD) survey was undertaken in Australia and New Zealand for calendar year 2013. Results and Conclusions For 2013, PMs sold as new implants in Australia was 15,203 (12,523 in 2009) and implanted in New Zealand were 1,641 (1,277 in 2009). The number of new PM implants per million population 652 for Australia (565 were in 2009) and 367 for New Zealand (299 in 2009). Although PM replacements rose in New Zealand, there was a fall in Australia as a result of improved power source service life. Pulse generator types sold in Australia were predominantly dual chamber 74% (71% in 2009) and implanted in New Zealand 59% (54% in 2009). There were 661 biventricular PMs implanted in Australia (446 in 2009) and 83 in New Zealand (45 in 2009). Transvenous pacing leads were overwhelmingly bipolar with preferences for active fixation leads, although, since 2009, there has been a minor resurgence in Australia of passive fixation lead usage in the atrium from 20 to ∼24%. There was also a marked increase in the ICD implants with 3904 new implants in Australia (3555 in 2009) and 423 in New Zealand (329 in 2009). The new ICD implants per million population were 167 for Australia (160 in 2009) and 95 for New Zealand (77 in 2009). Biventricular ICD implants increased significantly in both Australia (2211) and New Zealand (118).
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2014.09.017